| Financial Year |
March 31 2022 |
| Monetary Funds |
149,427,805.54 |
| Held-for-trading Financial Assets |
385,926,930.58 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,988,692.38 |
| Advances to Suppliers |
19,457,276.11 |
| Other Receivables |
12,598,282.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,416,506.15 |
| Total Current Assets |
577,815,492.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
15,057,635.48 |
| Investment Properties |
10,727,920.22 |
| Fixed Assetes |
20,067,797.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,081,949.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
906,253.69 |
| Deferred Income Tax Assets |
8,968,735.49 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,189,050,337.54 |
| Total Assets |
1,766,865,830.38 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
20,466,266.06 |
| Accounts Received In Advance |
3,973,107.08 |
| Employee Compensation Payable |
26,727,881.78 |
| Taxes Payable |
24,613,196.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,976,063.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,131,355.51 |
| Other Current Liabilities |
31,650.79 |
| Sub-Total of Current Liabilities |
89,331,848.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,700,000.00 |
| Deferred Income Tax Liabilities |
8,962,812.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,179,787.43 |
| Total Liabilities |
105,511,635.79 |
| Paid-In Capital(Or Share Stock) |
832,703,498.00 |
| Capital Surplus |
890,660,827.43 |
| Surplus Reserve |
22,893,969.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-899,068,079.69 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,661,354,194.59 |
| Owner's Equity（Stockholder's Equity） |
1,661,354,194.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,766,865,830.38 |
